24/7 Blood Pressure Monitoring Made Easy
Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom, Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 2, 2021 | Series A | $17.50M | 2 |
![]() |
— | Detail |
Mar 24, 2020 | Seed | Fr6M | 2 | — | — | Detail |
Sep 25, 2018 | Seed | Fr4M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series A |
![]() |
— | Series A |
|
— | Seed |